CAV1 and prostate carcinoma: CAV1 also interacts with the low-density lipoprotein receptor protein 6 (LRP6) and stimulates the kinase activities of the insulin and IGF-I receptors (IGF-IR/IR) in PC-3 cells, as well as in primary human prostate cancer tumors and metastases.